Skip to main content
Diabetes Care logoLink to Diabetes Care
. 2017 Jun 14;40(8):1133. doi: 10.2337/dc17-er08b

Erratum. Basal Glucose Can Be Controlled, but the Prandial Problem Persists—It’s the Next Target! Diabetes Care 2017;40:291–300

Matthew C Riddle
PMCID: PMC5521978  PMID: 28615239

In the above-mentioned article, there are two corrections to the text:

On page 294, in the second sentence under the heading “GLP-1 Receptor Agonists,” it reads “…dulaglutide (Tresiba)….” This should read “dulaglutide (Trulicity).”

On page 295, in the paragraph beginning, “A smaller but similarly designed study…,” in the sentence beginning “Glucose values were in the 70–80 mg/dL range…,” the sentence should read “Glucose values were in the 70–180 mg/dL range….”

The online version of this article has been corrected to reflect these changes.


Articles from Diabetes Care are provided here courtesy of American Diabetes Association

RESOURCES